{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:50:37Z","timestamp":1767340237622,"version":"3.41.2"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review will highlight the latest research relevant to the clinical care of traumatic brain injury (TBI) patients over the last 2 years while underscoring the implications of these advances in the understanding of diagnosis, treatment, and prognosis of TBI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Brain tissue oxygenation monitoring can identify hypoperfusion as an adjunct to intracerebral pressure monitoring. Multiple biomarker assays are now available to help clinicians screen for mild TBI and biomarker elevations correlate with the size of intracranial injury. Beta-blocker exposure following TBI has demonstrated a survival benefit in those with TBI though the mechanism for this remains unknown. The optimal timing for venous thromboembolism prophylaxis for TBI patients is still uncertain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The current characterization of TBI as mild, moderate, or severe fails to capture the complexity of the disease process and helps little with prognostication. Molecular biomarkers and invasive monitoring devices including brain tissue oxygenation and measures of cerebral autoregulation are being utilized more commonly and can help guide therapy. Extracranial complications following TBI are common and include infection, respiratory failure, coagulopathy, hypercoagulability, and paroxysmal sympathetic hyperactivity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001005","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T16:02:31Z","timestamp":1666886551000},"page":"715-724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Neurotrauma"],"prefix":"10.1097","volume":"28","author":[{"given":"Grace","family":"Niziolek","sequence":"first","affiliation":[{"name":"Division of Traumatology, Surgical Critical Care, and Emergency Surgery, Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle K.","family":"Sandsmark","sequence":"additional","affiliation":[{"name":"Division of Neurocritical Care, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Pascual","sequence":"additional","affiliation":[{"name":"Division of Traumatology, Surgical Critical Care, and Emergency Surgery, Department of Surgery"},{"name":"Division of Neurocritical Care, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(14)70120-6","article-title":"The Glasgow Coma Scale at 40\u200ayears: standing the test of time","volume":"13","author":"Teasdale","year":"2014","journal-title":"Lancet Neurol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1089\/neu.2021.0199","article-title":"Diagnosing level of consciousness: the limits of the Glasgow Coma Scale Total Score","volume":"38","author":"Bodien","year":"2021","journal-title":"J Neurotrauma"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/TA.0000000000000161","article-title":"The BIG (brain injury guidelines) project: defining the management of traumatic brain injury by acute care surgeons","volume":"76","author":"Joseph","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/TA.0000000000003633","article-title":"A multicenter validation of the modified brain injury guidelines: are they safe and effective?","volume":"93","author":"Khan","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"R7-20250729","first-page":"1095","article-title":"Relationship between brain tissue oxygen tension and CT perfusion: feasibility and initial results","volume":"26","author":"Hemphill","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/CCM.0000000000000720","article-title":"Accuracy of brain multimodal monitoring to detect cerebral hypoperfusion after traumatic brain injury\u2217","volume":"43","author":"Bouzat","year":"2015","journal-title":"Crit Care Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13054-022-03918-0","article-title":"Detection of cerebral hypoperfusion with a dynamic hyperoxia test using brain oxygenation pressure monitoring","volume":"26","author":"Gargadennec","year":"2022","journal-title":"Crit Care"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1179\/016164104225014094","article-title":"Influence of cerebral oxygenation following severe head injury on neuropsychological testing","volume":"26","author":"Meixensberger","year":"2004","journal-title":"Neurol Res"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1097\/CCM.0000000000005460","article-title":"Factors associated with brain tissue oxygenation changes after RBC transfusion in acute brain injury patients","volume":"50","author":"Gouvea Bogossian","year":"2022","journal-title":"Crit Care Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jocn.2022.03.017","article-title":"Effects of brain tissue oxygen (PbtO2) guided management on patient outcomes following severe traumatic brain injury: A systematic review and meta-analysis","volume":"99","author":"Hays","year":"2022","journal-title":"J Clin Neurosci"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1089\/neu.2021.0197","article-title":"Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury (COGiTATE): a feasibility randomized controlled clinical trial","volume":"38","author":"Tas","year":"2021","journal-title":"J Neurotrauma"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"103777","DOI":"10.1016\/j.ebiom.2021.103777","article-title":"Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study","volume":"75","author":"Whitehouse","year":"2022","journal-title":"EBioMedicine"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J Neurotrauma"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"eabg9922","DOI":"10.1126\/scitranslmed.abg9922","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","volume":"13","author":"Graham","year":"2021","journal-title":"Sci Transl Med"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/CCM.0000000000005055","article-title":"Association of early multiple organ dysfunction with clinical and functional outcomes over the year following traumatic brain injury: a transforming research and clinical knowledge in traumatic brain injury study","volume":"49","author":"Krishnamoorthy","year":"2021","journal-title":"Crit Care Med"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/0885066620972001","article-title":"Epidemiology and outcomes of acute respiratory distress syndrome following isolated severe traumatic brain injury","volume":"37","author":"Komisarow","year":"2022","journal-title":"J Intensive Care Med"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13054-017-1620-6","article-title":"Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study","volume":"21","author":"Rizoli","year":"2017","journal-title":"Crit Care"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.1097\/CCM.0000000000005076","article-title":"Admission features associated with paroxysmal sympathetic hyperactivity after traumatic brain injury: a case-control study","volume":"49","author":"Podell","year":"2021","journal-title":"Crit Care Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/TA.0b013e31802d02d0","article-title":"Beta-blocker exposure is associated with improved survival after severe traumatic brain injury","volume":"62","author":"Cotton","year":"2007","journal-title":"J Trauma"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/TA.0000000000001747","article-title":"Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma study","volume":"84","author":"Ley","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s00268-020-05391-8","article-title":"Beta-blocker therapy in severe traumatic brain injury: a prospective randomized controlled trial","volume":"44","author":"Khalili","year":"2020","journal-title":"World J Surg"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/TA.0000000000003516","article-title":"Traumatic brain injury patients with platelet inhibition receiving platelet transfusion demonstrate decreased need for neurosurgical intervention and decreased mortality","volume":"92","author":"Miles","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1089\/neu.2019.6911","article-title":"Impact of Antithrombotic Agents on Radiological Lesion Progression in Acute Traumatic Brain Injury: A CENTER-TBI Propensity-Matched Cohort Analysis","volume":"37","author":"Mathieu","year":"2020","journal-title":"J Neurotrauma"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.surg.2020.07.040","article-title":"Anticoagulation therapy in patients with traumatic brain injury: An Eastern Association for the Surgery of Trauma multicenter prospective study","volume":"169","author":"Matsushima","year":"2021","journal-title":"Surgery"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/neur.2021.0037","article-title":"Pharmaceutical venous thrombosis prophylaxis in critically ill traumatic brain injury patients","volume":"2","author":"Huijben","year":"2022","journal-title":"Neurotrauma Rep"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"e215794","DOI":"10.1001\/jamasurg.2021.5794","article-title":"Association of venous thromboembolism prophylaxis after neurosurgical intervention for traumatic brain injury with thromboembolic complications, repeated neurosurgery, and mortality","volume":"157","author":"Byrne","year":"2022","journal-title":"JAMA Surg"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2021.2043","article-title":"Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI Study","volume":"78","author":"McCrea","year":"2021","journal-title":"JAMA Neurol"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1097\/HTR.0000000000000575","article-title":"Influence of concomitant extracranial injury on functional and cognitive recovery from mild versus moderate to severe traumatic brain injury","volume":"35","author":"Carroll","year":"2020","journal-title":"J Head Trauma Rehabil"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(21)00374-4","article-title":"Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation","volume":"21","author":"Galimberti","year":"2022","journal-title":"Lancet Neurol"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:13:20Z","timestamp":1753820000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001005","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"type":"print","value":"1070-5295"},{"type":"electronic","value":"1531-7072"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}